Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-28, Stock:ABBV, The news for the past five days is as follows:
2018-12-20: NEWS1: Gilead Partners with Scholar Rock for Fibrotic Disease Drugs.NEWS2: AbbVie Rises 3%.NEWS3: Notable ETF Inflow Detected - XLV, ABBV, ABT, CVS.NEWS4: Notable ETF Inflow Detected - XLV, ABBV, ABT, CVS.NEWS5: AbbVie Submits New Drug Application to U.S. FDA and Marketing Authorization Application to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis.NEWS6: AbbVie to Present at the 37th Annual J.P. Morgan Healthcare Conference.NEWS7: 3 Top Healthcare Stocks to Buy in December.
2018-12-21: NEWS1: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS2: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS3: Noteworthy Friday Option Activity: CLVS, ABBV, AAL.NEWS4: Noteworthy Friday Option Activity: CLVS, ABBV, AAL.NEWS5: AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib.NEWS6: Gilead Partners with Scholar Rock for Fibrotic Disease Drugs.NEWS7: Gilead Partners with Scholar Rock for Fibrotic Disease Drugs.
2018-12-24: NEWS1: AbbVie (ABBV) Stock Moves -0.89%: What You Should Know.NEWS2: Lupin, AbbVie To Develop Novel Oncology Drug To Treat Hematological Cancers.NEWS3: Lupin, AbbVie To Develop Novel Oncology Drug To Treat Hematological Cancers.
2018-12-26: NEWS1: Health Care Sector Update for 12/26/2018: CAPR,IMMU,ABBV,NEOS,TEVA.NEWS2: Health Care Sector Update for 12/26/2018: CAPR,IMMU,ABBV,NEOS,TEVA.NEWS3: Health Care Sector Update for 12/26/2018: IMMU,ABBV,NEOS,TEVA.NEWS4: Health Care Sector Update for 12/26/2018: IMMU,ABBV,NEOS,TEVA.NEWS5: Will Big Pharma's Giant Maw Scoop Up These Small-Cap Players?.NEWS6: AbbVie Partners Lupin to Boost Hematological Cancer Pipeline.NEWS7: AbbVie Partners Lupin to Boost Hematological Cancer Pipeline.NEWS8: AbbVie Partners Lupin to Boost Hematological Cancer Pipeline.NEWS9: AbbVie Rises 3%.
2018-12-27: NEWS1: AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV.NEWS2: AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV.NEWS3: The Humira Overhang Can’t Cast a Shadow on AbbVie Stock Forever.NEWS4: ABBV February 2019 Options Begin Trading.NEWS5: ABBV February 2019 Options Begin Trading.NEWS6: AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV.

Answer: Rise